Colorectal cancer (CRC) is one of the most commonly diagnosed malignancies with a high incidence and mortality rate. An essential challenge in colorectal cancer management is to identify new prognostic factors that could better estimate the evolution and treatment responses of this disease. Considering their role in cancer development, progression and metastasis, miRNAs have become an important class of molecules suitable for cancer biomarkers discovery. We performed a systematic search of studies investigating the role of miRNAs in colorectal progression and liver metastasis published until October 2018. In this review, we present up-to-date information regarding the specific microRNAs involved in CRC development, considering their roles i...
Colorectal cancer (CRC) is known as the third most common cancer as well as the fourth most deadly c...
Colorectal cancer (CRC) is the third most common type of cancer worldwide amongst males and females....
Colorectal cancer (CRC) is currently the third and the second most common cancer in men and in women...
Metastatic disease is the major cause of death in colorectal cancer (CRC) patients. The metastatic p...
Colorectal cancer (CRC) is the third most fatal and fourth most frequently diagnosed neoplasm in the...
Colorectal cancer (CRC) is responsible for one of the major cancer incidence and mortality worldwide...
Colorectal cancer is one of the most common malignancies and is the second-leading cause of cancer-r...
peer reviewedColorectal cancer (CRC) accounts for one of the main cancer-related mortality and morbi...
Colorectal cancer (CRC) is one of the leading causes of cancer related deaths in the world. Many onc...
MicroRNAs (miRNAs) are a small non-coding RNAs that play a crucial role in cellular proliferation, d...
39 p.-6 fig.The process of liver colonization in colorectal cancer remains poorly characterized. Her...
Colorectal cancer (CRC) is a common condition and represents a lethal disease, following a sequentia...
poster abstractColorectal cancer (CRC) is the third most common malignancy worldwide. Liver metastas...
Background: Qualitative alterations or abnormal expression of microRNAs (miRNAs) in colon cancer hav...
Introduction: Colorectal cancer (CRC) is the second leading cause of cancer-related deaths worldwide...
Colorectal cancer (CRC) is known as the third most common cancer as well as the fourth most deadly c...
Colorectal cancer (CRC) is the third most common type of cancer worldwide amongst males and females....
Colorectal cancer (CRC) is currently the third and the second most common cancer in men and in women...
Metastatic disease is the major cause of death in colorectal cancer (CRC) patients. The metastatic p...
Colorectal cancer (CRC) is the third most fatal and fourth most frequently diagnosed neoplasm in the...
Colorectal cancer (CRC) is responsible for one of the major cancer incidence and mortality worldwide...
Colorectal cancer is one of the most common malignancies and is the second-leading cause of cancer-r...
peer reviewedColorectal cancer (CRC) accounts for one of the main cancer-related mortality and morbi...
Colorectal cancer (CRC) is one of the leading causes of cancer related deaths in the world. Many onc...
MicroRNAs (miRNAs) are a small non-coding RNAs that play a crucial role in cellular proliferation, d...
39 p.-6 fig.The process of liver colonization in colorectal cancer remains poorly characterized. Her...
Colorectal cancer (CRC) is a common condition and represents a lethal disease, following a sequentia...
poster abstractColorectal cancer (CRC) is the third most common malignancy worldwide. Liver metastas...
Background: Qualitative alterations or abnormal expression of microRNAs (miRNAs) in colon cancer hav...
Introduction: Colorectal cancer (CRC) is the second leading cause of cancer-related deaths worldwide...
Colorectal cancer (CRC) is known as the third most common cancer as well as the fourth most deadly c...
Colorectal cancer (CRC) is the third most common type of cancer worldwide amongst males and females....
Colorectal cancer (CRC) is currently the third and the second most common cancer in men and in women...